S&P 500   2,990.54 (-0.25%)
DOW   26,826.71 (-0.74%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
MSFT   138.05 (-1.17%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
F   9.29 (+1.98%)
NFLX   275.28 (-6.16%)
GILD   64.23 (-1.53%)
S&P 500   2,990.54 (-0.25%)
DOW   26,826.71 (-0.74%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
MSFT   138.05 (-1.17%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
F   9.29 (+1.98%)
NFLX   275.28 (-6.16%)
GILD   64.23 (-1.53%)
Log in

Scancell Stock Price, News & Analysis (LON:SCLP)

GBX 6.10
-0.25 (-3.94 %)
(As of 10/18/2019 02:47 PM ET)
Today's Range
6
Now: GBX 6.10
6.29
50-Day Range
6.10
MA: GBX 7.03
7.90
52-Week Range
3
Now: GBX 6.10
10.33
Volume429,631 shs
Average Volume536,966 shs
Market Capitalization£28.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-115-8231863

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 0.92 per share
Book ValueGBX 2.40 per share

Profitability

Miscellaneous

Employees19
Market Cap£28.39 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SCLP News and Ratings via Email

Sign-up to receive the latest news and ratings for SCLP and its competitors with MarketBeat's FREE daily newsletter.


Scancell (LON:SCLP) Frequently Asked Questions

What is Scancell's stock symbol?

Scancell trades on the London Stock Exchange (LON) under the ticker symbol "SCLP."

Has Scancell been receiving favorable news coverage?

News articles about SCLP stock have been trending neutral on Friday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Scancell earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Scancell.

Who are some of Scancell's key competitors?

What other stocks do shareholders of Scancell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scancell investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Petropavlovsk (POG), Ascential (ASCL), AorTech International (AOR), Advanced Oncotherapy (AVO), Empyrean Energy (EME), Lloyds Banking Group (LYG), Aminex (AEX) and Sound Energy (SOU).

Who are Scancell's key executives?

Scancell's management team includes the folowing people:
  • Dr. John Chiplin BPharm, MRPharmS, Ph.D., Exec. Chairman (Age 60)
  • Dr. Clifford Holloway, Chief Exec. Officer
  • Prof. Lindy Gillian Durrant Ph.D., Chief Scientific Officer & Director
  • Dr. Sally Elizabeth Adams, Devel. Director & Director (Age 58)
  • Mr. Keith Green, Director of Fin. & Admin.

How do I buy shares of Scancell?

Shares of SCLP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Scancell's stock price today?

One share of SCLP stock can currently be purchased for approximately GBX 6.10.

How big of a company is Scancell?

Scancell has a market capitalization of £28.39 million. Scancell employs 19 workers across the globe.View Additional Information About Scancell.

What is Scancell's official website?

The official website for Scancell is http://www.scancell.co.uk/.

How can I contact Scancell?

Scancell's mailing address is Department of Clinical Oncology Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The company can be reached via phone at +44-115-8231863.


MarketBeat Community Rating for Scancell (LON SCLP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  177 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  296
MarketBeat's community ratings are surveys of what our community members think about Scancell and other stocks. Vote "Outperform" if you believe SCLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Most Volatile Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel